Saving changes...

Done

Error

Angiogenic/Metronomic Strategies: Principles and Practice

Angiogenic/Metronomic Strategies: Principles and Practice

Angiogenic/Metronomic Strategies: Principles and Practice

Veterinary Cancer Society
Veterinary Cancer Society
on behalf of Missouri Veterinary Medical Association

$FREE $ FREE $ FREE

$ FREE $ FREE $ FREE
$ 37.50 $ 37.50 $ 37.50
Normal Price: FREE $37.50

Review:

Launch date: 08 Feb 2018
Expiry Date:

Last updated: 08 Feb 2018

Reference: 186948

This course is no longer available

Exam is embedded in the course
No preview available
No Exam Available

Latest User Comments

I would like to...

Course Availability

This course is only available to trainees days after purchase. It would need to be repurchased by the trainee if not completed in the allotted time period. This course is no longer available. You will need to repurchase if you wish to take the course again.

Description

This session will focus on clinical approaches to inhibit the growing tumor vasculature, including various targeted drug strategies and the use of metronomic chemotherapy protocols. Additional mechanisms for low dose metronomic chemotherapy, including immunomodulation and direct anti-cancer effects, will also be presented. A review of direct and indirect targeting of blood vessel growth, and combination treatment strategies involving anti-angiogenic, metronomic, and conventional oncologic therapy (surgery, radiation, maximum tolerated dose chemotherapy) will be incorporated. The importance of biomarkers to optimize the application of anti-angiogenic/metronomic therapy will be highlighted and clinical examples reviewed. Finally, an analysis of veterinary clinical trials will be presented involving a discussion of efficacy, tolerability/toxicity, and drug resistance.

Objectives

Objectives:
This session will focus on clinical approaches to inhibit the growing tumor vasculature, including various targeted drug strategies and the use of metronomic chemotherapy protocols. Additional mechanisms for low dose metronomic chemotherapy, including immunomodulation and direct anti-cancer effects, will also be presented. A review of direct and indirect targeting of blood vessel growth, and combination treatment strategies involving anti-angiogenic, metronomic, and conventional oncologic therapy (surgery, radiation, maximum tolerated dose chemotherapy) will be incorporated. The importance of biomarkers to optimize the application of anti-angiogenic/metronomic therapy will be highlighted and clinical examples reviewed. Finally, an analysis of veterinary clinical trials will be presented involving a discussion of efficacy, tolerability/toxicity, and drug resistance.
Veterinary Cancer Society

Author Information Play Video Bio

Veterinary Cancer Society
on behalf of Missouri Veterinary Medical Association

Dr. Anthony Mutsaers - Tony  graduated  from  the  Ontario  Veterinary  College  in 1997.  Following  a  year  of  private  practice  in  Newcastle Ontario he returned to OVC for a rotating internship in small animal  medicine  and  surgery,  followed  by  a  residency  in Oncology  at  Purdue  University .  He  is  a  Diplomate  of  the American  College  of  Veterinary  Internal  Medicine  in Oncology .  After his  residency  Tony  worked  as  a  clinical instructor  at the University of Queensland  in Brisbane, Australia.  He  then  returned  to  Canada  to  study  biomarkers  for  targeted oncology  drugs  at  the  Sunnybrook  Research  Institute,  culminating  in  a  PhD from  the  University  of  Toronto.  During  his  graduate  studies  he  practiced  part-time  as  a  medical  oncologist  at  OVC,  and  was  an  Adjunct  Professor  with  the Department  of  Clinical  Studies  from  2007  –  2010.  He  then  completed  a  post-doctoral  fellowship  at  the  St  Vincent’s  Institute  of  Medical  Research  in Melbourne,  Australia  studying  osteosarcoma.  In  2011  Tony  became  an Assistant  Professor  at  the  University  of  Guelph  with  a  joint  appointment  in  the Departments  of Clinical Studies and Biomedical Sciences.

Current Accreditations

This course has been certified by or provided by the following Certified Organization/s:

  • Missouri Veterinary Medical Association
  • 0.25 Hours -
    Exam Attempts: 3
    -
    Exam Pass Rate: 50

Faculty and Disclosures

Additional Contributors

Conflicts Declared

Conflicts of Interest declaration by Author:

null

User Reviews (0)

Go Back

Loading...


Saving changes...

Done

Error